Rare Find Cd11b Monoclonal Antibody (icrf44), Super Bright™ 600, Ebioscience™ Save 60% Now [ab94A0MZ]

CD11b Monoclonal Antibody: A Superior Tool for Flow Cytometry

The Rare Find Cd11b Monoclonal Antibody (icrf44), Super Bright™ 600, Ebioscience™ Save 60% Now [ab94A0MZ], is a cutting-edge reagent designed for precise and efficient flow cytometric analysis. This antibody, derived from mouse origin, offers a reliable tool for researchers investigating the role of CD11b in various biological processes. With its superior Super Bright™ 600 conjugation, it provides exceptional fluorescence intensity and clarity, making it ideal for complex staining protocols.

Product Features and Specifications

The CD11b Monoclonal Antibody (ICRF44) boasts several key features that make it a standout choice for researchers. First, it is a monoclonal antibody, ensuring consistency and specificity in its reactivity. The clone ICRF44 is known for its high affinity and specificity to human CD11b, making it a reliable reagent for detecting this adhesion molecule on various cell types, including monocytes, granulocytes, activated lymphocytes, and a subset of NK cells. The antibody is also tested and optimized for flow cytometric analysis, with a recommended testing dilution of 5 µL (0.25 µg)/test. This ensures accurate and reproducible results in your experiments.

Applications and Benefits

The CD11b Monoclonal Antibody (ICRF44) is a versatile tool with a wide range of applications in flow cytometry. Its broad reactivity profile includes baboon, chimpanzee, cynomolgus monkey, human, and rhesus monkey, making it suitable for cross-species studies. The Super Bright™ 600 conjugation allows for detection with a violet laser, emitting at 600 nm, which is compatible with most flow cytometers. Additionally, the antibody is purified through affinity chromatography, ensuring a high level of purity and minimizing the risk of non-specific binding. This product is designed for research use only and is not intended for diagnostic procedures or resale without express authorization.